DeepDx® Prostate, a clinically-validated AI for prostate core needle biopsy tissue image analysis. Whole-slide images (WSIs) of H&E-stained biopsy tissue specimens analyzed for prostate cancer, Gleason scores and grade group. Extensively tested at a US CLIA lab (>400k cores), DeepDx® Prostate alleviates the shortage of pathologists and the heavy workload, while reducing diagnostic subjectivity and variability.
Use Cases:
(1) 1st Read
(2) Concurrent Read
(3) Quality Control
(4) Research & Development
Key Features:
(1) Color Visualization and Gland-level Segmentation based on Gleason Patterns
(2) Proportion of Each Gleason Pattern Among the Three Patterns
(3) Tumor Length & Ratio Quantification
Performance Indicators:
(1) Sensitivity: 99%, Specificity: 97%
(2) Quadratic-Weighted Kappa: 0.92
(3) Reduction in Reading Time: 34%
(4) Average Seconds per Analysis: < 30
Note: From the latest clinical validation study, 2021
Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.
Contact usAre you interested in learning more? Please do not hesitate to get in touch with us at Sectra.
The application content is provided by the respective AI vendors.
